In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
Travere plans to file this application around the end of March using existing data from the phase 3 DUPLEX and phase 2 DUET studies. The company will request a priority review, which Leerink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback